Tiragolumab With Atezolizumab Plus Bevacizumab in Previously-Treated Advanced Non-squamous NSCLC

NCT04958811 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Non-squamous Non-small-cell Lung Cancer

Interventions

DRUG: Tiragolumab
DRUG: Atezolizumab
DRUG: Bevacizumab

Sponsor

Georgetown University

Collaborators

[object Object]